Tizanidine Tablet
Product Images NDC 63629-2370

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63629-2370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

FDA Label Image

Tizanidine-2 (Tizanidine 2)

FDA Label Image

Tizanidine-3 (Tizanidine 3)

FDA Label Image

Tizanidine-4 (Tizanidine 4)

Tizanidine-4 (Tizanidine 4)
The text describes the improvement in Ashworth Score at different stages of a study, including the mean dose used. The study lasted for 7 weeks, and the last observation was carried forward.*
FDA Label Image

Label (Lbl636292370)

Label (Lbl636292370)
This is a description of a prescription medication called Tizanidine Tablets, USP, with each tablet containing 2.288 mg of Tizanidine HCI. It is advised to keep this medication out of reach of children and to store it in a cool, dry, light-resistant place. Each bottle contains 1000 tablets, and it is only available with a prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.